{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:30:47Z","timestamp":1776299447576,"version":"3.50.1"},"reference-count":21,"publisher":"BMJ","issue":"8","funder":[{"name":"Biomedical Research Centre","award":["IS-BRC-1215-20007"],"award-info":[{"award-number":["IS-BRC-1215-20007"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2022,11,14]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                  <jats:title>Purpose<\/jats:title>\n                  <jats:p>To investigate frequency of germline pathogenic variants (PVs) in women with ductal carcinoma in situ (DCIS) and grade 1 invasive breast cancer (G1BC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We undertook <jats:italic>BRCA1\/2<\/jats:italic> analysis in 311\u2009women with DCIS and 392 with G1BC and extended panel testing (non-<jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic>) in 176\/311 with DCIS and 156\/392 with G1BC. We investigated PV detection by age at diagnosis, Manchester Score (MS), DCIS grade and receptor status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>30\/311 (9.6%) with DCIS and 16\/392 with G1BC (4.1%) had a <jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic> PV (p=0.003), and 24\/176-(13.6%) and 7\/156-(4.5%), respectively, a non-<jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic> PV (p=0.004). Increasing MS was associated with increased likelihood of <jats:italic>BRCA1\/2<\/jats:italic> PV in both DCIS and G1BC, although the 10% threshold was not predictive for G1GB. 13\/32 (40.6%) DCIS and 0\/17 with G1BC &lt;40\u2009years had a non-BRCA1\/2 PV (p&lt;0.001). 0\/16 DCIS G1 had a PV. For G2 and G3 DCIS, PV rates were 10\/98 (<jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic>) and 9\/90 (non-<jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic>), and 8\/47 (<jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic>) and 8\/45 (non-<jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic>), respectively. 6\/9 <jats:italic>BRCA1<\/jats:italic> and 3\/26 <jats:italic>BRCA2<\/jats:italic>-associated DCIS were oestrogen receptor negative-(p=0.003). G1BC population testing showed no increased PV rate (OR=1.16, 95% CI 0.28 to 4.80).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>DCIS is more likely to be associated with both <jats:italic>BRCA1\/2<\/jats:italic> and non-<jats:italic>BRCA1<\/jats:italic>\/<jats:italic>2<\/jats:italic> PVs than G1BC. Extended panel testing ought to be offered in young-onset DCIS where PV detection rates are highest.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jmg-2022-108790","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T13:21:09Z","timestamp":1669641669000},"page":"740-746","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers"],"prefix":"10.1136","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-5784","authenticated-orcid":false,"given":"D Gareth","family":"Evans","sequence":"first","affiliation":[{"name":"Division of Evolution and Genomic Science, The University of Manchester School of Health Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva","family":"Sithambaram","sequence":"additional","affiliation":[{"name":"Manchester Univerities Hospital NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8618-2332","authenticated-orcid":false,"given":"Elke Maria","family":"van Veen","sequence":"additional","affiliation":[{"name":"Division of Evolution and Genomic Sciences, The University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9360-8194","authenticated-orcid":false,"given":"George J","family":"Burghel","sequence":"additional","affiliation":[{"name":"Genomic Diagnostic Laboratory, MFT, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Schlecht","sequence":"additional","affiliation":[{"name":"North West Genomic Laboratory Hub, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine F","family":"Harkness","sequence":"additional","affiliation":[{"name":"Division of Evolution and Genomic Sciences, The University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Byers","sequence":"additional","affiliation":[{"name":"Genomic Medicine, The University of Manchester School of Health Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1137-9768","authenticated-orcid":false,"given":"Jamie M","family":"Ellingford","sequence":"additional","affiliation":[{"name":"Institute of Human Development, The University of Manchester School of Health Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-6201","authenticated-orcid":false,"given":"Ashu","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester Universities Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sacha J","family":"Howell","sequence":"additional","affiliation":[{"name":"Manchester Univerities Hospital NHS Foundation Trust, Manchester, UK"},{"name":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Howell","sequence":"additional","affiliation":[{"name":"Manchester Foundation Trust, Prevent Breast Cancer Centre, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8035-4471","authenticated-orcid":false,"given":"Claire","family":"Forde","sequence":"additional","affiliation":[{"name":"Clinical Genetics Service, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[{"name":"Clinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G","family":"Newman","sequence":"additional","affiliation":[{"name":"Genetics, The University of Manchester School of Health Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-0817","authenticated-orcid":false,"given":"Miriam Jane","family":"Smith","sequence":"additional","affiliation":[{"name":"Genetic Medicine, The University of Manchester School of Health Sciences, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-2855","authenticated-orcid":false,"given":"Emma Roisin","family":"Woodward","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, MFT, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"2025101713382141000_60.8.740.1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.15.1138"},{"key":"2025101713382141000_60.8.740.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.023"},{"key":"2025101713382141000_60.8.740.3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0146"},{"key":"2025101713382141000_60.8.740.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.8.964"},{"key":"2025101713382141000_60.8.740.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913948"},{"key":"2025101713382141000_60.8.740.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005936"},{"key":"2025101713382141000_60.8.740.7","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.6744","article-title":"Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes","volume":"8","author":"Mavaddat","year":"2022","journal-title":"JAMA Oncol"},{"key":"2025101713382141000_60.8.740.8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164154"},{"key":"2025101713382141000_60.8.740.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.03.009"},{"key":"2025101713382141000_60.8.740.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01234-6"},{"key":"2025101713382141000_60.8.740.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-011-9506-2"},{"key":"2025101713382141000_60.8.740.12","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.067850"},{"key":"2025101713382141000_60.8.740.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-019-1143-y","article-title":"Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50\u2009years","volume":"21","author":"Petridis","year":"2019","journal-title":"Breast Cancer Res"},{"key":"2025101713382141000_60.8.740.14","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.493","article-title":"BRCA1\/BRCA2 mutations in Japanese women with ductal carcinoma in situ","volume":"7","author":"Liu","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2025101713382141000_60.8.740.15","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4198-4"},{"key":"2025101713382141000_60.8.740.16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0698-3"},{"key":"2025101713382141000_60.8.740.17","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12174"},{"key":"2025101713382141000_60.8.740.18","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-09-0218"},{"key":"2025101713382141000_60.8.740.19","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2020-107347"},{"key":"2025101713382141000_60.8.740.20","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2009.065524"},{"key":"2025101713382141000_60.8.740.21","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-11-0775"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2022-108790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:38:30Z","timestamp":1760733510000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2022-108790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,7,21]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/jmg-2022-108790"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2022-108790","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}